London-based cybersecurity firm Inforcer closed a $50 million Series C round led by Insight Partners. The funding will support the company's mission to help smaller businesses navigate AI adoption and emerging security threats.
Inforcer provides security solutions designed for mid-market companies facing increased vulnerability to cyberattacks alongside rapid AI integration. The Series C funding expands the company's capabilities to address gaps in enterprise-grade protection for organizations without dedicated security teams.
The capital injection comes as businesses of all sizes confront dual pressures: adopting AI systems to remain competitive while protecting themselves against evolving attack vectors. Inforcer's platform aims to simplify security operations and risk management for resource-constrained teams.
Insight Partners' investment signals confidence in the market opportunity. SMBs represent a significant portion of the business ecosystem yet often lack the infrastructure and expertise of larger enterprises. Inforcer plans to use the funds to expand its product offerings and geographic reach.
The funding round marks Inforcer's continued growth in the cybersecurity sector, where demand for accessible, effective solutions remains strong amid heightened regulatory scrutiny and cyber threats.
Twilio stock surged after reporting record profitability and free cash flow that beat expectations. CEO Khozema Shipchandler sees significant untapped potential as AI becomes a larger revenue contributor.
DraftKings shares gained ground as the sportsbook operator leveraged World Cup viewership to drive customer acquisition and engagement. CEO Jason Robins attributed the company's stronger second-half outlook to both new and returning users attracted by the tournament.
Lyft CEO David Risher outlined the company's transformation into a global brand, signaling international expansion plans while comparing growth trajectories with autonomous vehicle competitor Waymo.
The White House is preparing an executive order claiming a connection between vaccines and autism, according to reports. The move contradicts decades of scientific research finding no link between the two.